Navigation Links
The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
Date:9/30/2008

The HeartAssist 5™ Pediatric VAD will be introduced for the first time in the U.S. at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston on Oct. 2-4.

HOUSTON (Business Wire EON) September 30, 2008 -- The Modern DeBakey VAD™ is the only pediatric ventricular assist device (VAD) that benefited from years of hands-on leadership and support by Dr. Michael DeBakey. It is the only VAD to feature the DeBakey name and the only FDA-approved pediatric VAD in the world.

Originally created through a collaboration between Dr. DeBakey, colleague Dr. George Noon, NASA and the Baylor College of Medicine, it is one of the smallest VADs in the world. It can support the failing left ventricle of the heart with blood flow of 1-10 L/min.

The U.S. introduction of the HeartAssist 5™ Pediatric VAD, The Modern DeBakey VAD™, occurs less than three months after the internationally renowned surgeon's death from natural causes. Dr. DeBakey passed away at age 99 on July 11. He would have celebrated his 100th birthday on September 7, 2008.

Rodger G. Ford, who led the buyout of then public MicroMed Cardiovascular, Inc. and took the company private on August 25, 2008, described his meetings with Dr. DeBakey as "…a humbling experience. I left our meetings exuberant at Dr. DeBakey's interest and support."

The HeartAssist 5™ Pediatric VAD is the only VAD with the exclusive direct flow measurement system, which provides measurement of blood flow through the VAD. Since pediatric VADs are designed to support failing hearts in children, precise blood flow measurement can prove vital for patients in critical condition. At best, other devices only approximate blood flow, which can be unreliable, or provide no blood flow data at all.

The HeartAssist 5™ Pediatric VAD pump weighs only 92 grams and measures just 2.8 x 1.2 inches. Because of its small size, it is one of the few pediatric VADs that can be implanted above the diaphragm in the pericardial space surrounding the heart, which reduces the risk of complications.

  • DeBakey will be honored multiple times during this week. On the evening of Oct. 1, Dr. Noon and heart assist device leaders will celebrate the grand re-opening of the International Center for Medical Technologies museum and hold an ISRBP presidential reception in honor of Dr. DeBakey

  • following afternoon at the opening session of ISRBP, Dr. Noon and associates will pay tribute to Dr. DeBakey and his lifelong accomplishments in heart surgery and the DeBakey VAD. There will also be a Tribute to Dr. Michael E. DeBakey and Awards Gala on Oct. 3.

  • 1995, with the help of Drs. DeBakey and Noon, MicroMed Cardiovascular was formed to license and commercialize NASA technology. The result of their work was the first human implant of a rotary ventricular assist device, the DeBakey VAD, in 1998.

  • the U.S., the HeartAssist 5™, formerly DeBakey VAD Child, is the only FDA-approved pediatric VAD and a bridge-to-transplant IDE clinical study is underway for adult use. In Europe, the HeartAssist 5™ is CE Mark approved for both adult and pediatric use. The HeartAssist 5™ Straight VAD is CE Mark approved for patients with previous surgeries or complicated anatomies. It is designed to be implanted through the less invasive left thoracotomy.

Humanitarian Device: The HeartAssist 5™ Pediatric VAD is authorized by Federal law for use in providing temporary mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients 5-16 years old who are listed for transplant. The effectiveness of this device for this use has not been demonstrated.

Read the full story at http://www.prweb.com/releases/debakey/pediatric/prweb1406304.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. European Centre for Modern Drug Discovery Established in Hamburg
2. Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com
3. Modernizing Continuing Education With Online Courses
4. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
5. Halal-Certified Products Introduced Into SAFC Supply Solutions Flavors & Fragrances Food-Grade Line
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
8. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
9. Genmab Announces 2007 First Half Year Results
10. Pharsight Achieves First License Sale for Public-Source Database
11. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. :  HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System 
(Date:3/28/2017)... ... 28, 2017 , ... Ecovia Renewables, Inc. announced today that ... from the National Science Foundation (NSF). Under the award , Ecovia Renewables, ... BioGel™ biopolymer materials for hygiene applications, particularly for use in the absorbent cores ...
(Date:3/28/2017)... , March 28, 2017 ... better understand Enzo Biochem and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/28/2017)... , Belgium , March 28, 2017 ... VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of ... DVD Associates, LLC, as a strategic consultant. Dr. Vollmer ... identifying and securing non-dilutive funding in the State ... United States . Dr. Vollmer Dahlke has ...
(Date:3/28/2017)... 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), ... novel therapies for metabolic and endocrine disorders, today announced ... Ph.D., will deliver a corporate presentation at H.C. Wainwright ... being held April 3, 2017 at the St. Regis ... this presentation are as follows: ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
Breaking Biology News(10 mins):